iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Short Interest Down 34.0% in April

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) was the target of a large drop in short interest in April. As of April 30th, there was short interest totaling 1,522 shares, a drop of 34.0% from the April 15th total of 2,307 shares. Based on an average daily volume of 1,233 shares, the days-to-cover ratio is currently 1.2 days. Approximately 1.0% of the shares of the stock are sold short.

iShares Neuroscience and Healthcare ETF Price Performance

IBRN opened at $34.79 on Monday. The company’s 50 day simple moving average is $33.44 and its two-hundred day simple moving average is $32.22. iShares Neuroscience and Healthcare ETF has a 1-year low of $21.78 and a 1-year high of $37.00. The firm has a market capitalization of $5.22 million, a price-to-earnings ratio of 15.61 and a beta of 0.77.

iShares Neuroscience and Healthcare ETF Company Profile

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.